Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/15/2882983/28652/en/Aileron-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Business-Highlights.html
https://www.globenewswire.com/news-release/2024/05/06/2876136/28652/en/Aileron-Therapeutics-to-Present-at-Two-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/03/2875352/28652/en/Aileron-Therapeutics-Announces-Closing-of-Underwritten-Registered-Direct-Offering-of-up-to-Approximately-40-Million.html
https://www.globenewswire.com/news-release/2024/05/01/2873263/28652/en/Aileron-Therapeutics-Announces-Pricing-of-Underwritten-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules-of-up-to-Approximately-40-Million.html
https://www.globenewswire.com/news-release/2024/05/01/2873251/28652/en/Aileron-Therapeutics-Announces-Positive-Data-from-Cohort-1-of-the-Phase-1b-Clinical-Trial-of-LTI-03-in-Idiopathic-Pulmonary-Fibrosis-IPF.html
https://www.globenewswire.com/news-release/2024/04/15/2863221/28652/en/Aileron-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/03/12/2844479/28652/en/Aileron-Therapeutics-Announces-CEO-Transition.html
https://www.globenewswire.com//news-release/2024/02/15/2830371/28652/en/Aileron-Therapeutics-and-Pulmonary-Care-Experts-To-Discuss-the-Potential-Implications-of-LTI-03-for-Idiopathic-Pulmonary-Fibrosis-in-Virtual-Key-Opinion-Leader-Event.html
https://www.globenewswire.com//news-release/2024/02/01/2822483/28652/en/Aileron-Therapeutics-to-Host-Key-Opinion-Leader-Event-on-February-15-2024.html
https://www.prnewswire.com/news-releases/aileron-therapeutics-announces-acquisition-of-lung-therapeutics-301973050.html